DTC MAX: 4 Devices (7 billing codes)

DTC MAX are four (4) individual and evidence-based FDA Cleared modalities that identify and measure the autonomic nervous system (ANS), diabetic peripheral neuropathy (DPN), peripheral arterial disease (PAD), diabetic retinal exam (DRE), tilt table (optional) and also includes:

Four separate devices (ANS+DPN+DRE+PAD)
Five assessments
Seven eligible billing codes (not including office visits)
New 2023 Guidelines (diabetes, prediabetes, obesity, hypertension, and metabolic syndrome)
Three (3) years of practice consulting up to 1 hour monthly
Three (3) year license as a Diabetes Testing Center™
Three (3) years of billing support
Three (3) months of certified diabetes education video
Three (3) year extended manufacturer warranty

Screening for Major Complications

4 Test with 7 Billing Codes

The DTC PRO are medical devices with the following:

Diabetic Retinopathy Exam (DRE) www.DMeyes.org Diabetic Retinopathy is an eye condition that can cause vision loss and blindness in people and should not be confused with an ophthalmoscope eye exam. 50% of diabetic patients lack documentation of a retinal eye exam which is the most difficult HEDIS measure to meet. Therefore, insurance companies are grateful for assistance to close the gap in care.
Diabetic Neuropathy Device™ (DND) www.DPNtest.org is the First FDA Cleared Multi-Objective Innovation that Identifies, and Measures Peripheral Neuropathy.
Autonomic Nervous System (ANS) www.ANStest.org device is FDA Cleared and Measures Arterial Stiffness, Vascularization, and Endothelial Function.

TruPAD™ www.TruPAD.org is a medical device that measures Peripheral Artery Disease (PAD), a condition in which the large and medium-sized arteries supply blood to the legs and become narrow or clogged with plaque, constricting blood flow.

Features of the tests:

Below is a financial pro forma for a popular bundle:

Financial Pro Forma

Note: Does not include revenue from office visits.

1 DM Patient ≈ $500

$5K Day* (10 DM Patients x $500)

$110K Monthly ($5K x 22 Days)

$1.3 Million Yearly ($110K x 12 Months)

10 DM Patients ≈ 40 Standard Patients

You have DM
Over age 65
Over age 50 and have a history of diabetes or smoking
Under age 50, but have diabetes and other PAD risk factors, such as obesity or high BP